生命科学资讯

Secretive Rampart Bioscience closes after pursuing non-viral gene therapy

Other news to note for Jan. 8, 2026

Regulatory actions for Jan. 8, 2026

Inflarx focuses on izicopan as biopharma spending cuts continue

Moonlake preps for sonelokimab BLA in HS; no new trials needed

FDA rejects Vanda’s Hetlioz for jet lag disorder

FDA rejects Vanda’s jet lag drug following yearslong dispute

Lexeo Therapeutics, J&J team up to test heart pump technology for cardiac gene therapy delivery

Flagship-founded Tessera plans to lay off 90 employees in March

GSK inks a model deal in $50M bet on Noetik's cancer AI platform

Startup Spiro Medical snares $67M in series A funding for asthma treatment

HHS loses bid to suspend court block on 340B rebate pilot

Parabilis, chasing ‘undruggable’ targets, nabs $305M amid VC funding blitz

Deregulating the rapidly evolving digital health industry

Charles River CEO Jim Foster to retire; Samsung Bio buys a GSK factory

From Forever Chemicals to Ancient Proteins: Five Science Stories from 2025

Ventyx’s NLRP3 inhibitors best in class? Lilly offers $1.2B

Illumina and PREMIA partner to expand clinical access to CGP in Asia - The Manila Times

IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation | Science

Chinese Immune Multi-Omics Atlas | Science